
An anti-Cancer drug first developed in East Germany during the Cold War has made it to Australia's Pharmaceutical Benefits Scheme.
Published
Updated
By Luke Waters
Presented by Maridel Martinez
Source: SBS
Skip to podcast episode contentShare this with family and friends
An anti-Cancer drug first developed in East Germany during the Cold War has made it to Australia's Pharmaceutical Benefits Scheme.
The treatment significantly prolongs the quality and expectancy of life for patients diagnosed with some forms of Lymphoma.